|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
CA2366152A1
(en)
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Streptococcus pneumoniae vaccine
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
EP1189624A4
(en)
|
1999-06-29 |
2005-02-23 |
Epimmune Inc |
Hla binding peptides and their uses
|
|
FR2798128B1
(fr)
|
1999-09-06 |
2001-11-16 |
Inst Nat Sante Rech Med |
Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla
|
|
WO2001058479A1
(en)
|
2000-02-08 |
2001-08-16 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
JP2003524016A
(ja)
|
2000-02-23 |
2003-08-12 |
エピミューン， インコーポレイテッド |
Ｈｌａ結合ペプチドおよびそれらの用途
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
CA2480008C
(en)
|
2002-03-22 |
2015-10-06 |
The Penn State Research Foundation |
Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
|
|
JP2006512300A
(ja)
|
2002-10-03 |
2006-04-13 |
エピミューン インコーポレイテッド |
Ｈｌａ結合ペプチド及びその使用
|
|
CN1954217B
(zh)
|
2004-02-06 |
2013-05-08 |
国立健康与医学研究所 |
衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
|
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
CA2672215A1
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
KR101543624B1
(ko)
*
|
2007-08-20 |
2015-08-11 |
온코세라피 사이언스 가부시키가이샤 |
Ｆｏｘｍ１ 펩티드 및 이를 포함하는 약학적 조성물
|
|
PT2119726E
(pt)
|
2008-05-14 |
2015-03-30 |
Immatics Biotechnologies Gmbh |
Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano
|
|
US20110182926A1
(en)
|
2008-08-12 |
2011-07-28 |
Nicola La Monica |
Minigene
|
|
ES2536465T3
(es)
*
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
|
TWI469791B
(zh)
*
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
US20110033389A1
(en)
|
2009-04-29 |
2011-02-10 |
Zhifeng Chen |
Modified antibodies for passive immunotherapy
|
|
JP5722334B2
(ja)
|
2009-11-03 |
2015-05-20 |
コリア・ユニバーシティ・リサーチ・アンド・ビジネス・ファウンデーション |
酸化亜鉛−結合性ペプチドを含むタンパク質と酸化亜鉛ナノ粒子の複合体及びその用途
|
|
GB201004575D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
|
|
US9314516B2
(en)
|
2010-05-04 |
2016-04-19 |
Cassian Yee |
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses
|
|
WO2012027379A2
(en)
|
2010-08-24 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
US20140371302A1
(en)
|
2011-12-29 |
2014-12-18 |
Modema Therapeutics, Inc. |
Modified mrnas encoding cell-penetrating polypeptides
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
CA2902415C
(en)
|
2012-03-19 |
2024-02-06 |
Stemline Therapeutics, Inc. |
Methods for treating and monitoring the status of cancer
|
|
WO2013148147A1
(en)
|
2012-03-26 |
2013-10-03 |
The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services |
Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
WO2013173411A1
(en)
|
2012-05-16 |
2013-11-21 |
Stemline Therapeutics, Inc |
Cancer stem cell targeted cancer vaccines
|
|
US20140141044A1
(en)
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
EP2929045B1
(en)
|
2012-12-05 |
2020-12-02 |
SOLA Biosciences LLC |
Protein expression enhancing polypeptides
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
GB201315946D0
(en)
|
2013-09-06 |
2013-10-23 |
Immune Targeting Systems Its Ltd |
Oncology vaccine
|
|
AU2015271324B2
(en)
|
2014-06-06 |
2019-09-12 |
Herlev Hospital |
Determining antigen recognition through barcoding of MHC multimers
|
|
WO2016146143A1
(en)
|
2015-03-16 |
2016-09-22 |
Amal Therapeutics Sa |
Cell penetrating peptides and complexes comprising the same
|
|
SG11201706418QA
(en)
|
2015-03-31 |
2017-10-30 |
Agency Science Tech & Res |
Method for antigen loading of dendritic cells and vaccine
|
|
SG11201802881YA
(en)
*
|
2015-10-08 |
2018-05-30 |
Oncotherapy Science Inc |
Foxm1-derived peptide, and vaccine including same
|
|
US12018331B2
(en)
|
2016-05-23 |
2024-06-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
IL296165B2
(en)
|
2016-10-07 |
2023-10-01 |
Enterome S A |
Immunogenic compounds for cancer treatment
|
|
CN117801069A
(zh)
|
2016-10-07 |
2024-04-02 |
恩特罗姆公司 |
用于癌症疗法的免疫原性化合物
|
|
US11712465B2
(en)
|
2016-10-07 |
2023-08-01 |
Enterome S.A. |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
AU2018348432B2
(en)
|
2017-10-09 |
2025-08-28 |
Enterome S.A. |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
US20210106652A1
(en)
|
2018-04-11 |
2021-04-15 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
|
|
MX2022004598A
(es)
|
2019-10-16 |
2022-09-23 |
Enterome S A |
Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
|
|
PL4021487T3
(pl)
|
2019-11-15 |
2024-04-15 |
Enterome S.A. |
Peptydy antygenowe do zapobiegania i leczenia nowotworów złośliwych wywodzących się z limfocytów b
|